MAPK1 and cancer: These authors advance that increased ERK activity accompanies a high proliferative activity in cancer cells leading to a negative regulation of the enzyme pyruvate kinase isoform M2 (PKM2, responsible for PEP to pyruvate conversion), through phosphorylation.